China grants the first patent for the Corona vaccine

Official media, citing documents from the China Intellectual Property Regulatory Authority, stated that Cansino Biology Corporation has obtained approval from Beijing for a patent for a vaccine (AD5-NSOV) against COVID-19.

The official People's Daily said on Sunday that this is the first patent granted by China for a vaccine for COVID-19.

The newspaper quoted documents published by the National Intellectual Property Administration of China as saying that the patent was issued on August 11.

Saudi Arabia said this month that it plans to start a third phase of clinical trials of the cancino vaccine. Cansino said it was also in talks with Russia, Brazil and Chile to start the third phase of testing in those countries.

Source Reuters